| NG | nasogastric; neoplastic growth; new growth; nitroglycerin; nodose ganglion; no growth; not given |
|---|---|
| ECGS | endothelial cell growth supplement |
| CVA | 1) Cardio-Vascular Accident(Attack) 2) Cerebro-Vascular Accident(Attack);... |
| CVD | 1) Cerebro-Vascular Disease; 심장 혈관병(증) = CVA &n... |
| PVD | patient very disturbed; peripheral vascular disease; portal vein dilation; posterior vitreous detach... |
| PD-ECGF | Platelet-derived endothelial cell growth factor |
|---|---|
| PD-ECGF/TP | Platelet-derived endothelial cell growth factor/thymidine phosphorylase |
| HUVEC | Human umbilical vascular endothelial cells |
| HUVEC | Human vascular endothelial cells |
| VEC | Vascular Endothelial Cells |
| fibroblast growth factor, basic | A single-chain polypeptide of approximately 15-16 kD which has been isolated from a variety of cells. It has a 55% amino acid residue identity to acidic fibroblast growth factor and has potent heparin-binding activity. However, in contrast to the acidic fibroblast growth factor, heparin does not potentiate the biological activities of bfgf. The growth factor is an extremely potent inducer of DNA synthesis in a variety of normal diploid mammalian cell types from mesoderm and neuroectoderm lineages and promotes cellular differentiation in vitro. (12 Dec 1998) |
|---|---|
| fibroblast growth factor receptor | Family of receptor tyrosine kinases for fibroblast growth factor. (18 Nov 1997) |
| fibroblast growth factor receptor-like embryonic kinase | <enzyme> Found in avian embryonic tissue; involved in early differentiation of skeletal muscle. Registry number: EC 2.7.1.- Synonym: frek (26 Jun 1999) |
| platelet endothelial cell activated protease | <enzyme> Degrades casein and fibrinogen; secreted by endothelial cells and activated in the extracellular medium by platelets; not inhibited by serine protease inhibitors, metalloproteinase inhibitors, or cystein protease inhibitors; pH optimum 7.5 Registry number: EC 3.4.99.- Synonym: pecap (26 Jun 1999) |
| corneal endothelial polymorphism | A greater than normal variation in the shape of the cells. (05 Mar 2000) |
| high endothelial postcapillary venules | Venule's in the lymph nodes, tonsils, and Peyer's patches that have a high-walled endothelium through which blood lymphocytes migrate into the lymphatic parenchyma. (05 Mar 2000) |
| intravascular papillary endothelial hyperplasia | A benign florid papillary endothelial proliferation within the veins of the skin or subcutis, less often in visceral blood vessels. Synonym: Masson's pseudoangiosarcoma. (05 Mar 2000) |
| iridocorneal endothelial syndrome | <syndrome> Syndrome of glaucoma, iris atrophy, decreased corneal endothelium, anterior peripheral synechia, and multiple iris nodules. Synonym: Cogan-Reese syndrome, iris-nevus syndrome. (05 Mar 2000) |
| endothelial | Pertaining to or made up of endothelium. (16 Dec 1997) |
| endothelial cell | A thin, flattened cell, a layer of them lines the inside surfaces of body cavities, blood vessels, and lymph vessels, making up the endothelium. (09 Oct 1997) |
| endothelial cyst | A serous cyst whose sac is lined with endothelium. (05 Mar 2000) |
| endothelial dystrophy of cornea | Spontaneous loss of corneal endothelium leading to oedema of the corneal stroma and epithelium. (05 Mar 2000) |
| endothelial leukocyte | Old term for a monocyte, a type of leukocyte thought to be derived from reticuloendothelial tissue. (05 Mar 2000) |
| endothelial-leukocyte adhesion molecule | 115,000 Mw molecule on the surface of endothelial cells that is involved in blood leukocyte attachment to vessel walls as well as emigration from the vessels into the tissues. (05 Mar 2000) |
| endothelial myeloma | A malignant primary bone tumour that arises most commonly in the first three decades of life. It is highly malignant (prone to spread) and often requires treatment with some combination of radiation therapy and chemotherapy. (27 Sep 1997) |